Evaluating Men's Telehealth Programs
Evaluate men’s telehealth affiliate programs by service scope, geography, payout terms and approved promotional assets using a publisher-focused checklist.
Read the guideTelehealth / Men's Health / TRT
Category 02 · Private access
Men's health memberships built around lab testing and clinician-guided testosterone therapy have loyal, long-lived customers. They also involve a controlled substance and a federal telemedicine rule with a deadline. Here's what publishers need to know.
Last reviewed October 4, 2026

Men who suspect low testosterone often research for a long time before acting. They want to know what testing involves, what treatment costs, and whether a program is legitimate. Telehealth TRT programs answer that with at-home or local lab testing, a clinician consultation, and an ongoing membership if treatment is prescribed.
For publishers, the appeal is retention. TRT is typically an ongoing therapy with regular labs and follow-ups, so programs value patients over many months and often reward partners with recurring or hybrid commissions. The audience also clusters around content publishers already reach: fitness, men's health, longevity and podcasts.
Who the patients are: adult men, often 30 to 60, researching symptoms, testing and costs. They respond to straight talk about the process and are put off by bodybuilding-style hype.
Programs usually start with lab work. A licensed clinician reviews the results and health history, and decides whether testosterone therapy or another approach is appropriate. If treatment is prescribed, the membership covers medication, follow-up labs, dose adjustments and clinician access.
| Program type | What the patient gets | Typical conversion event |
|---|---|---|
| Testing first | A lab panel and results review, with treatment offered only if appropriate | Paid lab kit or lab order |
| Full TRT membership | Labs, clinician consults, prescription and ongoing monitoring | First paid month |
| Broader men's health | Hormone care alongside other men's health services | Membership sign-up |
Commissions in this category lean toward revenue share and hybrid models because of long patient lifetimes, alongside CPA on the first paid month. Terms are shared with approved publishers.
Testosterone is a Schedule III controlled substance. Under rules that began during the COVID-19 emergency, DEA-registered clinicians can prescribe Schedule II to V controlled substances by telemedicine without first seeing the patient in person. In December 2025 DEA and HHS extended those flexibilities for a fourth time, through December 31, 2026.
What happens after that depends on further federal action. A program might add an in-person step, change its process, or adjust which states it serves. MarketHealth asks every TRT advertiser for its plan before recruiting publishers, and we'll update briefs if the rules change. Don't write content that promises "no in-person visit ever" unless the advertiser has approved that wording.
We track the December 31 deadline and DEA's replacement rule on the telehealth regulation tracker.
Paid search and paid social are approval-required. Platforms restrict ads for prescription drugs and controlled substances, and certification belongs to the provider.
Testosterone therapy is prescribed for diagnosed conditions after clinical evaluation. Marketing that treats it as a performance, anti-aging or bodybuilding product invites trouble with platforms and regulators. These rules apply to every TRT offer, on top of the brief:
More detail is in the TRT section of the compliance guide.
The TRT market includes excellent programs and some that cut corners. Before you put your name behind one, check:
Programs that monitor patients properly keep them longer, and that's what drives the recurring commissions this category is known for.
Tip: "Should I get tested?" content converts better and more safely than "Do you have low T?" checklists. It puts the clinician in charge, which is where the rules want it.
Part of men's health: TRT sits within the men's telehealth category, alongside ED programs, premature ejaculation and fertility. Telemedicine prescribing of testosterone relies on DEA flexibilities that run through December 31, 2026; check the regulation tracker before you plan content past that date.
For advertisers: run a TRT or men's health program and want vetted publishers? Tell us about your program and we'll reply within one business day. Share your program details.
FAQ
Related guides
Evaluate men’s telehealth affiliate programs by service scope, geography, payout terms and approved promotional assets using a publisher-focused checklist.
Read the guideEvaluate men’s health affiliate offers with transparent criteria for audience fit, evidence, terms and support, plus a clearly hypothetical scoring example.
Read the guidePlan a men’s health affiliate website with audience research, a topic map, relevant offer selection, content review and a practical editorial calendar.
Read the guideBuild a 12-week men’s wellness affiliate content calendar with practical topics, formats, review steps and relevant links to verified offers and resources.
Read the guidePrivate access
Telehealth offers on MarketHealth are available by approval only. Applications are reviewed by a person, not a script.
MarketHealth has programs in this category. Apply through our Telehealth Publishers page to discuss the campaigns suited to your audience.
Advertiser identities, payouts, creatives, tracking links and campaign-specific terms are shared privately after the relevant approval. This page is a publisher recruitment resource, not a consumer treatment or pharmacy order page.
This category is relevant to men’s-health publishers, podcasts and relevant wellness communities.
Focus on medical evaluation and lab review. Keep hormone therapy distinct from over-the-counter testosterone-support supplements.
Lab requirements, clinician coverage, approved traffic and the campaign’s qualifying event.
Your brief also identifies approved traffic sources, landing pages, required disclosures and the conversion event used for attribution.